High frequency of activated K‐ras codon 15 mutant in colorectal carcinomas from Taiwanese patients

Colorectal carcinogenesis is regarded as a multistep process resulting from accumulation of genetic alterations, including activation of protooncogenes and inactivation of tumor suppressor genes via signal transduction trigger the stage‐wise progression to malignancy. The reported incidence of K‐ras mutation detected in general tissue samples ranges from 21–60% in primary colorectal cancers (CRC). To assess the prevalence and spectrum of K‐ras mutations in Taiwanese patients with CRC, we analyzed 65 CRC patients by polymerase chain reaction‐single strand conformation polymorphism analysis, followed by direct sequencing. K‐ras mutations were detected in 43.1% (28 of 65) of the tumors. The mutational hot spots were located at codons 12, 13, 15 and 20, especially with the highest frequency at codon 15. To understand whether the codon 15 mutations in CRC were associated with activation of K‐ras oncogene and the alterations of its biocharacteristics, mutant K‐ras genes were cloned from tumor tissues and then inserted into expression vector pBKCMV to construct the prokaryotic expression plasmid pK15MCMV. Mutant K‐ras genes were expressed at high levels in E. coli and the mutant K‐ras proteins were shown to be functional with respect to their well‐known specific, high‐affinity, GDP/GTP binding. The purified K‐ras protein from E. coli was then measured for its intrinsic GTPase activity and the extrinsic GTPase activity in the presence of GTPase‐activating protein for ras. We found that the extrinsic GTPase activity of the codon 15 mutant K‐ras proteins (p21K‐ras15M) in the presence of GAP is much lower than that of the wild‐type K‐ras protein (p21 BN), whereas the intrinsic GTPase activity is nearly the same as that of the wild‐type K‐ras protein. The results indicated that mutation at the codon 15 of K‐ras gene indeed decreased GTPase activity in CRC, however, its association with tumorigenesis of CRC needs be clarified by further studies. © 2003 Wiley‐Liss, Inc.